Trends in the incidence of basal cell carcinoma by histopathological subtype
- PMID: 20840348
- DOI: 10.1111/j.1468-3083.2010.03839.x
Trends in the incidence of basal cell carcinoma by histopathological subtype
Abstract
Background: As a result of the high prevalence, basal cell carcinoma (BCC) causes a significant and expensive health care problem.
Objective: In this study, we evaluate the proportional increase in BCC by histological subtype over the last two decades.
Methods: We retrospectively reviewed all primary histological confirmed BCCs diagnosed in the Maastricht University Medical Centre in The Netherlands in the years 1991, 1999 and 2007.
Results: An annual increase of the number of BCCs of 7% for both genders was shown. The age-standardized incidence rates for BCC increased between 1991 and 2007 from 54.2 to 162.1 per 100, 000 men and from 61.7 to 189.8 per 100, 000 women. The proportion of superficial BCC increased significantly from 17.6% to 30.7%.
Conclusion: The incidence of BCC is continuing to increase this century. The observed shift to the superficial histological subtype, which can be treated non-surgically, might reduce the workload in the busy dermatologists practice.
© 2010 The Authors. Journal of the European Academy of Dermatology and Venereology © 2010 European Academy of Dermatology and Venereology.
Similar articles
-
Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands.Acta Derm Venereol. 2011 Jan;91(1):24-30. doi: 10.2340/00015555-1009. Acta Derm Venereol. 2011. PMID: 21264452
-
Predictions of skin cancer incidence in the Netherlands up to 2015.Br J Dermatol. 2005 Mar;152(3):481-8. doi: 10.1111/j.1365-2133.2005.06386.x. Br J Dermatol. 2005. PMID: 15787817
-
Increase in basal cell carcinoma incidence steepest in individuals with high socioeconomic status: results of a cancer registry study in The Netherlands.Br J Dermatol. 2009 Oct;161(4):840-5. doi: 10.1111/j.1365-2133.2009.09222.x. Epub 2009 May 12. Br J Dermatol. 2009. PMID: 19438849
-
Epidemiology and aetiology of basal cell carcinoma.Br J Dermatol. 2007 Dec;157 Suppl 2:47-51. doi: 10.1111/j.1365-2133.2007.08273.x. Br J Dermatol. 2007. PMID: 18067632 Review.
-
Clinical histopathological characteristics of basal cell carcinoma in Japanese patients.Arch Dermatol. 1996 Mar;132(3):320-4. Arch Dermatol. 1996. PMID: 8607638 Review.
Cited by
-
Predicting the Risk of a Second Basal Cell Carcinoma.J Invest Dermatol. 2015 Nov;135(11):2649-2656. doi: 10.1038/jid.2015.244. Epub 2015 Mar 3. J Invest Dermatol. 2015. PMID: 26121210
-
Adequacy of surgical margins, re-excision, and evaluation of factors associated with recurrence: a retrospective study of 769 basal cell carcinomas.An Bras Dermatol. 2023 Jul-Aug;98(4):449-459. doi: 10.1016/j.abd.2022.07.005. Epub 2023 Mar 16. An Bras Dermatol. 2023. PMID: 36934062 Free PMC article.
-
Photodynamic therapy combined with cryotherapy for the treatment of nodular basal cell carcinoma.Oncol Lett. 2013 Oct;6(4):939-941. doi: 10.3892/ol.2013.1504. Epub 2013 Jul 31. Oncol Lett. 2013. PMID: 24137440 Free PMC article.
-
Patient Preferences and Cosmetic Outcomes Following Destructive Treatments for Non-facial Basal Cell Carcinoma: A Mixed Methods Study.Acta Derm Venereol. 2025 Feb 12;105:adv41325. doi: 10.2340/actadv.v105.41325. Acta Derm Venereol. 2025. PMID: 39936608 Free PMC article. Clinical Trial.
-
Novel Approaches in Non-Melanoma Skin Cancers-A Focus on Hedgehog Pathway in Basal Cell Carcinoma (BCC).Cells. 2022 Oct 13;11(20):3210. doi: 10.3390/cells11203210. Cells. 2022. PMID: 36291078 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials